Skip to main content
Figure 4 | Journal of Experimental & Clinical Cancer Research

Figure 4

From: Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT

Figure 4

Binding of hDM-αH-C6.5 MH3B1 to ECDHER2. (A), Interaction of ECDHER2 with hDM-αH-C6.5 MH3B1 immobilized on the surface of a SPR chip. ECDHER2 at concentrations of a) 100 nM in duplicate b) 50 nM in duplicate c) 40 nM d) 20 nM in duplicate or e) 10 nM was flowed across the sensor chip at 30 μl/min for 750 second. f) Binding of 100 nM ECDHER2 to immobilized hDM-αH-C6.5 MH3B1 after incubation with 1 μM hDM-αH-C6.5 MH3B1. (B), Binding of biotinylated hDM-αH-C6.5 MH3B1 to ECDHER2 expressed on the cell surface. Bound protein was detected using Streptavidin-PE. Left panel shows binding of 0.5 μg of biotinylated hDM-αH-C6.5 MH3B1 to CT26HER2/neu and not to the parental cells that lack HER2/neu expression. Right panel shows binding of 0.1 μg (heavy green), or 0.5 μg of biotinylated hDM-αH-C6.5 MH3B1 (thin blue) or Streptavidin-PE (heavy black) to MCF-7HER2 cells. Filled are unstained cells.

Back to article page